The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salomon, B.
Right arrow Articles by Klatzmann, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salomon, B.
Right arrow Articles by Klatzmann, D.

The Journal of Immunology, Vol 152, Issue 2 537-548, Copyright © 1994 by American Association of Immunologists


ARTICLES

Conditional ablation of dendritic cells in transgenic mice

B Salomon, P Lores, C Pioche, P Racz, J Jami and D Klatzmann
Laboratorie de Biologie et Genetique des Pathologies Immunitaires, Centre National de la Recherche Scientifique URA 1463, Paris, France.

Dendritic cells (DC) are professional Ag-presenting cells that play a major role in T cell-mediated immune responses and in thymocyte differentiation. To better analyze their physiological importance, we sought to generate transgenic mice presenting a conditional DC deficiency. We used a strategy based on the cell-specific expression of a suicide gene. The DC-targeted expression is obtained using HIV regulatory sequences; indirect evidence has suggested that these sequences control a preferential expression in DC. The suicide gene is the herpes simplex virus type 1 thymidine kinase (HSV1-TK) which allows conditional ablation of dividing HSV1-TK-expressing cells by converting nucleoside analogs such as ganciclovir (GCV) into toxic molecules. We generated transgenic mice expressing an HSV1-TK gene transcribed from HIV regulatory sequences. A low but significant HSV1-TK expression was observed in mature DC and DC precursors grown from granulocyte- macrophage colony-stimulating factor-supplemented bone marrow cultures. These HSV1-TK-expressing DC precursors are specifically killed by GCV. We next treated transgenic mice with GCV, and obtained a specific ablation of DC in spleen and thymus. Ninety percent of spleen DC could be depleted within a week, indicating a turnover rate of approximately 15% per day. Interestingly, this DC depletion always correlated with a major thymic atrophy and disappearance of CD4+CD8+ thymocytes. This animal model should help to assess the physiological role of DC in the immune response and in thymocyte differentiation. It should also help to appreciate the consequences of DC dysfunction in pathological situations, such as HIV-infection or allograft rejection.


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
W. Allaerts and H. Vankelecom
History and perspectives of pituitary folliculo-stellate cell research
Eur. J. Endocrinol., July 1, 2005; 153(1): 1 - 12.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W. Jalabi, N. Boehm, D. Grucker, and M. S. Ghandour
Recovery of Myelin after Induction of Oligodendrocyte Cell Death in Postnatal Brain
J. Neurosci., March 16, 2005; 25(11): 2885 - 2894.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. H. Burnett, E. J. Kershen, J. Zhang, L. Zeng, S. C. Straley, A. M. Kaplan, and D. A. Cohen
Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene
J. Leukoc. Biol., April 1, 2004; 75(4): 612 - 623.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Kusmartsev, F. Cheng, B. Yu, Y. Nefedova, E. Sotomayor, R. Lush, and D. Gabrilovich
All-trans-Retinoic Acid Eliminates Immature Myeloid Cells from Tumor-bearing Mice and Improves the Effect of Vaccination
Cancer Res., August 1, 2003; 63(15): 4441 - 4449.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Kawahata, Y. Misaki, M. Yamauchi, S. Tsunekawa, K. Setoguchi, J.-i. Miyazaki, and K. Yamamoto
Peripheral Tolerance to a Nuclear Autoantigen: Dendritic Cells Expressing a Nuclear Autoantigen Lead to Persistent Anergic State of CD4+ Autoreactive T Cells After Proliferation
J. Immunol., February 1, 2002; 168(3): 1103 - 1112.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. T. Kamath, J. Pooley, M. A. O'Keeffe, D. Vremec, Y. Zhan, A. M. Lew, A. D'Amico, L. Wu, D. F. Tough, and K. Shortman
The Development, Maturation, and Turnover Rate of Mouse Spleen Dendritic Cell Populations
J. Immunol., December 15, 2000; 165(12): 6762 - 6770.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. C. KIPS, K. G. TOURNOY, and R. A. PAUWELS
Gene Knockout Models of Asthma
Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): S66 - 70.
[Full Text] [PDF]


Home page
BloodHome page
D. T.-L. Roux, V. Roullot, C. Poujol, T. Kortulewski, P. Nurden, and G. Marguerie
Thrombasthenic mice generated by replacement of the integrin alpha IIb gene: demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment
Blood, August 15, 2000; 96(4): 1399 - 1408.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R.-K. Zhong, A. D. Donnenberg, H.-F. Zhang, S. Watkins, J.-H. Zhou, and E. D. Ball
Human Blood Dendritic Cell-Like B Cells Isolated by the 5G9 Monoclonal Antibody Reactive with a Novel 220-kDa Antigen
J. Immunol., August 1, 1999; 163(3): 1354 - 1362.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Gabrilovich, T. Ishida, T. Oyama, S. Ran, V. Kravtsov, S. Nadaf, and D. P. Carbone
Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo
Blood, December 1, 1998; 92(11): 4150 - 4166.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Masurier, B. Salomon, N. Guettari, C. Pioche, F. Lachapelle, M. Guigon, and D. Klatzmann
Dendritic Cells Route Human Immunodeficiency Virus to Lymph Nodes after Vaginal or Intravenous Administration to Mice
J. Virol., October 1, 1998; 72(10): 7822 - 7829.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. N. Lambrecht, B. Salomon, D. Klatzmann, and R. A. Pauwels
Dendritic Cells Are Required for the Development of Chronic Eosinophilic Airway Inflammation in Response to Inhaled Antigen in Sensitized Mice
J. Immunol., April 15, 1998; 160(8): 4090 - 4097.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. J. M. Leenen, K. Radosevic, J. S. A. Voerman, B. Salomon, N. van Rooijen, D. Klatzmann, and W. van Ewijk
Heterogeneity of Mouse Spleen Dendritic Cells: In Vivo Phagocytic Activity, Expression of Macrophage Markers, and Subpopulation Turnover
J. Immunol., March 1, 1998; 160(5): 2166 - 2173.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S Patterson, N. English, H Longhurst, P Balfe, M Helbert, A. Pinching, and S. Knight
Analysis of human immunodeficiency virus type 1 (HIV-1) variants and levels of infection in dendritic and T cells from symptomatic HIV-1- infected patients
J. Gen. Virol., February 1, 1998; 79(2): 247 - 257.
[Abstract]


Home page
J. Immunol.Home page
B. Salomon, J. L. Cohen, C. Masurier, and D. Klatzmann
Three Populations of Mouse Lymph Node Dendritic Cells with Different Origins and Dynamics
J. Immunol., January 15, 1998; 160(2): 708 - 717.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. N.J. Hart
Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response
Blood, November 1, 1997; 90(9): 3245 - 3287.
[Full Text] [PDF]


Home page
BloodHome page
J. L. Cohen, O. Boyer, B. Salomon, R. Onclercq, F. Charlotte, S. Bruel, G. Boisserie, and D. Klatzmann
Prevention of Graft-Versus-Host Disease in Mice Using a Suicide Gene Expressed in T Lymphocytes
Blood, June 15, 1997; 89(12): 4636 - 4645.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.